CoChat

Acceleration of leukocytes’ epigenetic age as an early tumor and sex-specific marker of breast and colorectal cancer

Open access
Durso, Danielle Fernandes, Bacalini, Maria Giulia, Sala, Claudia, Pirazzini, Chiara, Marasco, Elena, Bonafé, Massimiliano, do Valle, Ítalo Faria, Gentilini, Davide, Castellani, Gastone, Faria, Ana Maria Caetano, Franceschi, Claudio, Garagnani, Paolo, Nardini, Christine · 2017 · Oncotarget
Cited by 107

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

// Danielle Fernandes Durso 1, 2, * , Maria Giulia Bacalini 3, * , Claudia Sala 4, 9 , Chiara Pirazzini 3 , Elena Marasco 1 , Massimiliano Bonafé 1 , Ítalo Faria do Valle 4 , Davide Gentilini 5 , Gastone Castellani 4, 9 , Ana Maria Caetano Faria 6 , Claudio Franceschi 3, * , Paolo Garagnani 1, 7, 8, 9, * , Christine Nardini 10, 11, * 1 Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum-University of Bologna, Bologna, Italy 2 National Counsel of Technological and Scientific Development (CNPq), Ministry of Science Technology and Innovation (MCTI), Brasilia, Brazil 3 IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy 4 Department of Physics and Astronomy, University of Bologna, Bologna, Italy 5 Istituto Auxologico Italiano IRCCS, Cusano Milanino, Milan, Italy 6 Biochemistry and Immunology Department, Biological Sciences Institute, Federal University of Minas Gerais, Belo Horizonte, Brazil 7 Applied Biomedical Research Center, S. Orsola-Malpighi Polyclinic, Bologna, Italy 8 Interdepartmental Center “L. Galvani”, University of Bologna, Bologna, Italy 9 Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden 10 Personal Genomics S.r.l., Verona, Italy 11 CNR IAC “Mauro Picone”, Rome, Italy * These authors contributed equally to this work Correspondence to: Christine Nardini, email: christine.nardini.rsrc@gmail.com Paolo Garagnani, email: paolo.garagnani2@unibo.it Claudio Franceschi, email: claudio.franceschi@unibo.it Keywords: epigenetic clock, ELOVL2, FHL2, cancer, blood Received: October 19, 2016 Accepted: February 12, 2017 Published: February 21, 2017 ABSTRACT Changes in blood epigenetic age have been associated with several pathological conditions and have recently been described to anticipate cancer development. In this work, we analyze a publicly available leukocytes methylation dataset to evaluate the relation between DNA methylation age and the prospective development of specific types of cancer. We calculated DNA methylation age acceleration using five state-of-the-art estimators (three multi-site: Horvath, Hannum, Weidner; and two CpG specific: ELOV2 and FHL2) in a cohort including 845 subjects from the EPIC-Italy project and we compared 424 samples that remained cancer-free over the approximately ten years of follow-up with 235 and 166 subjects who developed breast and colorectal cancer, respectively. We show that the epigenetic age estimated from blood DNA methylation data is statistically significantly associated to future breast and male colorectal cancer development. These results are corroborated by survival analysis that shows significant association between age acceleration and cancer incidence suggesting that the chance of developing age-related diseases may be predicted by circulating epigenetic markers, with a dependence upon tumor type, sex and age estimator. These are encouraging results towards the non-invasive and perspective usage of epigenetic biomarkers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.15573

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

Metadata

Authors
Durso, D. F., Bacalini, M. G., Sala, C., Pirazzini, C., Marasco, E., Bonafé, M., do Valle, Í. F., Gentilini, D., Castellani, G., Faria, A. M. C., Franceschi, C., Garagnani, P., & Nardini, C.
Venue
Oncotarget
Published
2017-02-21
Volume
8
Issue
14
Pages
23237-23245
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2590469096
Cited by
107
References
18
FWCI
4.46
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.